Alternatives to EyeGate Pharmaceuticals

AI-powered eye exam for early detection of neurodegenerative diseases like Alzheimer's.

A global oncology company developing and commercializing innovative cancer treatments.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI-powered platform accelerating biological research and drug discovery.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Developing novel male contraceptives.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.